State of Wisconsin Investment Board’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$263K Sell
18,911
-19,576
-51% -$268K ﹤0.01% 2268
2025
Q4
$531K Buy
38,487
+4,967
+15% +$117K ﹤0.01% 1925
2025
Q3
$819K Sell
33,520
-36,742
-52% -$895K ﹤0.01% 1687
2025
Q2
$1.62M Buy
70,262
+19,297
+38% +$508K ﹤0.01% 1389
2025
Q1
$1.38M Buy
50,965
+10,232
+25% +$386K ﹤0.01% 1380
2024
Q4
$2.18M Buy
40,733
+8,148
+25% +$431K 0.01% 1257
2024
Q3
$1.48M Buy
32,585
+1,843
+6% +$80.2K ﹤0.01% 1431
2024
Q2
$1.29M Buy
30,742
+6,752
+28% +$317K ﹤0.01% 1468
2024
Q1
$903K Buy
23,990
+8,869
+59% +$193K ﹤0.01% 1457
2023
Q4
$162K Buy
15,121
+4,655
+44% +$40.3K ﹤0.01% 2232
2023
Q3
$105K Sell
10,466
-2,736
-21% -$31.6K ﹤0.01% 2359
2023
Q2
$157K Buy
13,202
+1,647
+14% +$22K ﹤0.01% 2185
2023
Q1
$140K Buy
+11,555
New +$192K ﹤0.01% 2340
2022
Q2
Sell
-17,700
Closed -$254K 2845
2022
Q1
$254K Buy
+17,700
New +$290K ﹤0.01% 2127

Other funds holding JANX

State of Wisconsin Investment Board's JANX Position: Q1 2026 in Review

State of Wisconsin Investment Board reduced its Janux Therapeutics (JANX) stake by 51% in Q1 2026, selling an estimated $268K and leaving 18,911 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #2268.

State of Wisconsin Investment Board first reported a position in JANX in Q1 2022 and has held it in 14 quarters since. The position peaked at $2.18M in Q4 2024. 190 funds tracked by Wall St. Rank hold JANX as of Q1 2026.

  • State of Wisconsin Investment Board held 18,911 shares of Janux Therapeutics worth $263K as of Q1 2026.
  • State of Wisconsin Investment Board sold 19,576 Janux Therapeutics shares in Q1 2026, an estimated $268K.
  • Janux Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #2268 holding.
  • State of Wisconsin Investment Board first reported a position in Janux Therapeutics in Q1 2022 and has held it in 14 quarters since.
  • State of Wisconsin Investment Board's Janux Therapeutics position peaked at $2.18M in Q4 2024.
  • 190 funds tracked by Wall St. Rank held Janux Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.